IONS 250516 37.50P(IONS250516P37500) Stock Price Today

Clear

All

Quotes

News

Learn

Help

All

News

Announcements

No matches yet

Operations too frequent. Please try again later.

Please check network settings and try again Refresh Refresh

History record

IONS250516P37500

Watchlist

0.00
0.000.00%

15min DelayTrading May 7 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

Express News | Ionis Pharmaceuticals Inc : Jefferies Raises Target Price to $83 From $77
Reuters43minutes ago
Ionis to Host 2025 Virtual Annual Meeting of Stockholders
BusinesswireMay 6 07:05 ET
Ionis Pharmaceuticals Independent Director Acquires 40% More Stock
Simply Wall StMay 5 08:48 ET
Earnings Beat: Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
Simply Wall StMay 3 09:11 ET
Director Makes Bold Move With Major Stock Purchase in Ionis Pharmaceuticals
TipRanksMay 2 22:07 ET
Ionis Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations
Yahoo FinanceMay 2 09:10 ET

Comments

Teddy123

Apr 16 19:12

IonQ Signs MoU with Intellian, Deepening Its Commitment to Advancing South Korea’s Quantum Economy

$Ionis Pharmaceuticals (IONS.US)$
IonQ Takes Quantum Computing to Space: New Satellite Tech Partnership Expands Korean Presence

Teddy123

Mar 12 10:52

Ionis and Ono announce global license agreement for sapablursen in polycythemia vera

$Ionis Pharmaceuticals (IONS.US)$
Massive $940M Deal: Ionis Partners with Ono on Breakthrough Blood Cancer Treatment

Teddy123

Mar 10 19:21

WAINZUA (eplontersen) approved in the EU for the treatment of hereditary transthyretin-mediated amyloidosis in adults with stage 1 or stage 2 polyneuropathy

$Ionis Pharmaceuticals (IONS.US)$
WAINZUA (eplontersen) approved in the EU for the treatment of hereditary transthyretin-mediated amyloidosis in adults with stage 1 or stage 2 polyneuropathy

The conservative Man

Dec 20, 2024 22:46

$Ionis Pharmaceuticals (IONS.US)$ got a good FDA approval and it’s going down crazy 😎

Meltyy

Dec 17, 2024 15:56

📌 1 PDUFA this weekand 6 more upcoming this month! 🚀

🔔 This Week’s PDUFA:
$Ionis Pharmaceuticals (IONS.US)$ : 🤔
⇨ IONIS-APOCIII-LRx (Olezarsen)
‣ FCS (Familial chylomicronemia syndrome)
‣ PDUFA: 12/19/24 (NDA)
🗓️ Last Week’s PDUFA Decisions:
$Checkpoint Therapeutics (CKPT.US)$ : Approved 12/13/24 ✅
⇨ UNLOXCYT (cosibelimab-ipdl)
‣ metastatic or locally advanced cSCC (cutaneous squamous cell carcinoma)
‣ PDUFA: 12/28/24 (resubmitted BLA)
$Neurocrine Biosciences (NBIX.US)$ : Approved 12/13/24 ✅
⇨ CRENESSITY™ (crin...